Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ·Healthcare·Biotechnology
$2.26
-4.64%
Mkt Cap $6.34M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$9.00
Range $9.00 – $9.00
Implied Upside
+298.2%
Consensus $9.00 vs current $2.26
NASDAQ·Healthcare·Biotechnology
$2.26
-4.64%
Mkt Cap $6.34M
No recent rating data.
Price Target (1 analysts)
$9.00
Range $9.00 – $9.00
+298.2%
Consensus $9.00 vs current $2.26